research 413 DC-HIL+ myeloid-derived suppressor cells are elevated in the peripheral blood and lesional skin of cutaneous lupus patients
Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.
Search
for
Sort by
Research
990-1000 / 1000+ results 
research MALASSEZIA FUNGAL DERMATITIS AND RHIPICEPHALUS SANGUINEUS TICK INFESTATION IN MIXED BREED DOGS
The dog's skin condition improved with treatment, and prevention includes keeping it dry, clean, and away from stray dogs.
research Navigating Rhupus Complexity
Rhupus is a complex syndrome that is hard to diagnose due to unclear clinical criteria.
research Tufted hair folliculitis in a patient affected by pachydermoperiostosis: case report and videodermoscopic features.
The patient improved significantly after treatment, with only one small scar remaining.
research Doughnut wart formation after cryotherapy of viral wart in a patient with alopecia areata
A doughnut-shaped wart can form after cryotherapy in people with alopecia areata due to immune system issues.
research Natural course of epidermolysis bullosa simplex with mottled pigmentation in a Japanese family with the p.P25L mutation in KRT 5
The p.P25L mutation in the KRT5 gene causes a rare skin condition that worsens over time and may lead to hair loss starting in young adulthood.
research Efficacy of a topical formulation of Henna (Lawsonia inermis) on the itch and wound healing in patients with epidermolysis bullosa: A pilot single-arm clinical trial
Henna ointment may help reduce itching and improve wound healing in patients with epidermolysis bullosa.
research 494 Epidermolysis bullosa pruriginosa, muscular dystrophy, and immune-mediated myasthenia gravis in a patient with homozygous nonsense PLEC mutation
A patient with a PLEC mutation has epidermolysis bullosa, muscular dystrophy, and myasthenia gravis, which improved with steroid treatment.
research Cutaneous Adverse Reactions to IL-17 and IL-23 Inhibitors: A Clinical Review of Reaction Patterns
IL-17 and IL-23 inhibitors, used for treating moderate-to-severe psoriasis and other inflammatory diseases, can cause a range of cutaneous adverse reactions. These reactions include common psoriasiform and eczematous eruptions, as well as less frequent conditions like lupus-like syndromes and bullous pemphigoid. The mechanisms are thought to involve changes in immune signaling rather than direct drug toxicity. Management depends on the severity and type of reaction, with options ranging from topical treatments to discontinuation of the drug. Recognizing these reactions is crucial due to their similarity to primary dermatologic diseases, and further research is needed to better understand their incidence and management.
research A case of acquired acrodermatitis enteropathica with a normal serum zinc level but a low level in the hair
Zinc supplements can help skin issues even if blood zinc levels are normal.